We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
-12.34%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
AUM
$469M
AUM Growth
+$6.3M
Cap. Flow
+$69M
Cap. Flow %
14.71%
Top 10 Hldgs %
56.27%
Holding
170
New
29
Increased
62
Reduced
27
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 40.87%
2 Industrials 5.56%
3 Financials 4.87%
4 Consumer Discretionary 3.12%
5 Healthcare 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
51
Microsoft
MSFT
$2.84T
$1.3M 0.28%
12,842
+802
+7% +$85.9K
IJH icon
52
iShares Core S&P Mid-Cap ETF
IJH
$123B
$1.17M 0.25%
35,255
+25,155
+249% +$918K
AAXJ icon
53
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
$1.14M 0.24%
+17,911
New +$1.16M
INTC icon
54
Intel
INTC
$466B
$1.07M 0.23%
22,875
+1,940
+9% +$90.8K
MRK icon
55
Merck
MRK
$324B
$1.05M 0.22%
14,339
+81
+0.6% +$5.72K
BCE icon
56
BCE
BCE
$19.9B
$1.02M 0.22%
25,415
BUSE icon
57
First Busey Corp
BUSE
$2.52B
$1.02M 0.22%
41,433
IWD icon
58
iShares Russell 1000 Value ETF
IWD
$82B
$1.02M 0.22%
9,161
+7,274
+385% +$872K
ITOT icon
59
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
$1.01M 0.22%
+17,753
New +$1.09M
NWL icon
60
Newell Brands
NWL
$2.16B
$1M 0.21%
+53,838
New +$1.07M
VV icon
61
Vanguard Large-Cap ETF
VV
$51.9B
$983K 0.21%
8,562
-235
-3% -$29.1K
PFE icon
62
Pfizer
PFE
$140B
$960K 0.2%
23,184
+242
+1% +$10K
VYX icon
63
NCR Voyix
VYX
$1.06B
$944K 0.2%
66,636
+81
+0.1% +$1.27K
ITA icon
64
iShares US Aerospace & Defense ETF
ITA
$14.2B
$927K 0.2%
10,728
-11,110
-51% -$1.07M
JAX
65
DELISTED
J. Alexander's Holdings, Inc.
JAX
$892K 0.19%
108,381
KO icon
66
Coca-Cola
KO
$354B
$889K 0.19%
18,769
+12
+0.1% +$574
KRE icon
67
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$880K 0.19%
18,803
-17,825
-49% -$953K
BMY icon
68
Bristol-Myers Squibb
BMY
$127B
$866K 0.18%
16,657
+1,000
+6% +$53.7K
JNJ icon
69
Johnson & Johnson
JNJ
$635B
$864K 0.18%
6,692
+18
+0.3% +$2.51K
EPD icon
70
Enterprise Products Partners
EPD
$83.8B
$841K 0.18%
34,208
FEZ icon
71
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$840K 0.18%
25,233
-10,327
-29% -$363K
BRK.B icon
72
Berkshire Hathaway Class B
BRK.B
$1.07T
$835K 0.18%
4,091
+1,540
+60% +$322K
KBE icon
73
State Street SPDR S&P Bank ETF
KBE
$1.64B
$817K 0.17%
21,872
-9,779
-31% -$415K
CTG
74
DELISTED
Computer Task Group, Inc.
CTG
$803K 0.17%
196,778
+90,000
+84% +$413K
IJK icon
75
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$778K 0.17%
+16,272
New +$852K

Similar funds

Crescent Grove Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Crescent Grove Advisors held 170 positions worth $469M, up 1.4% from $463M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Crescent Grove Advisors deployed $69M of net new capital in Q4 2018, opening 29 new positions and adding to 62 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 107,474 shares worth $7.45M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 43% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $2.86M trimmed.

  • Crescent Grove Advisors's largest Q4 2018 buy was iShares Core S&P Small-Cap ETF: 107,474 shares worth $7.45M.
  • Crescent Grove Advisors added most to iShares Core MSCI EAFE ETF in Q4 2018, an estimated $13.7M increase.
  • Crescent Grove Advisors's biggest Q4 2018 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $2.86M.
  • Crescent Grove Advisors fully exited Zurn Elkay Water Solutions in Q4 2018, selling an estimated $8.31M.
  • Crescent Grove Advisors's ten largest holdings make up 56% of its $469M portfolio in Q4 2018.
  • Crescent Grove Advisors opened 29 new positions and closed 12 in Q4 2018.
  • Crescent Grove Advisors's portfolio value rose 1.4% quarter-over-quarter to $469M.

Based on Crescent Grove Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.